SUMMARY A major reason for the conflicting views conceming prognosis in epilepsy has been the failure to account for the temporal aspects of seizure relapse and remission. In this paper prognostic studies in a variety of areas are reviewed to emphasise this point. Most traditional studies (including studies of withdrawal of medication) show a generally poor prognosis for epilepsy. These have been hospital-based and, as such, inevitably over-represent patients with chronic epilepsy. Investigations (both hospital and community based) of patients from the onset of seizures show a much better prognosis, and most patients suffer only a small number of seizures in total over a relatively short period of time and then remit. The longer the epilepsy is active the less likely is eventual remission, but once remission is achieved it is usually permanent. The
SUMMARY A major reason for the conflicting views conceming prognosis in epilepsy has been the failure to account for the temporal aspects of seizure relapse and remission. In this paper prognostic studies in a variety of areas are reviewed to emphasise this point. Most traditional studies (including studies of withdrawal of medication) show a generally poor prognosis for epilepsy. These have been hospital-based and, as such, inevitably over-represent patients with chronic epilepsy. Investigations (both hospital and community based) of patients from the onset of seizures show a much better prognosis, and most patients suffer only a small number of seizures in total over a relatively short period of time and then remit. The longer the epilepsy is active the less likely is eventual remission, but once remission is achieved it is usually permanent. The traditional view of epilepsy as a chronic condition with a continuing tendency to relapse is therefore not tenable for the majority of patients. The patterns of epilepsy are established relatively early in its course in most cases, and long term prognosis might therefore be predictable within a few years of the onset of seizures in most patients. Prior to the introduction of effective treatment, it was said that epilepsy rarely remitted, and it is possible that early treatment may actually improve long term prognosis.
Since the classic work of Gowers,' there have been a panoply of studies of prognosis in epilepsy. Typically, these have found prognosis to be poor, and the concept of epilepsy as a chronic condition characterised by a continuing tendency to seizure relapse has grown up and is of course widely accepted. Recent work, has challenged this, and the key to this disagreement may lie in the failure to appreciate the importance of the temporal aspects of the epilepsy:
that is to say, in any individual case, the pattern and timing of previous relapse and remission. Here I will elaborate on this concept, and examine prognostic 1158 and its combinations, hundreds of epileptics have been cured, and thousands are leading useful lives who would otherwise have been incapacitated by the disease". The possibility that treatment, by suppressing the "self perpetuation" of seizures in the short term, might in fact lessen the long term tendency to recurrence is inferred in Gowers' work, and I shall return to this later. Suffice to say here that as drug treatment has become almost universally obtainable, all subsequent prognostic investigations have been of the treated disease, and the opportunities now available to study untreated seizures are few.
Hospital and institution based prognostic studies Almost all traditional prognostic studies have been carried out from hospital clinic or institution, and it is data from these studies that form the basis of most widely held views of prognosis. In such clinical settings, patients with chronic or uncontrolled epilepsy are inevitably over-represented, and those with newly diagnosed seizures or epilepsy in remission under-represented. The central importance of this selection bias has been usually ignored.
A most important landmark in the study of prognosis was the publication in 1968 of Rodin' s book The Prognosis ofPatients with Epilepsy. In this were summarised most previous prognostic studies, which were almost without exception hospital or institution based and in the form of retrospective (or partially retrospective) surveys. From this review, Rodin drew a number of conclusions, and I will single out three of these. First, he accepted that the overall prognosis of epilepsy was poor; he found from his review that only "approximately one-third of all epileptic patients are likely to achieve a terminal remission of at least two years." In table 1 1 have Shorvon listed all the general prognostic studies ii, which terminal remission rates (or over 12 months) were 3 -16 given, and these seem to confirm his findings. Secondly, addressing the problem of length of follow up, he noted that relapse after short term remission was common, and that the longer a patient was followed the more likely was relapse, and concluded that, with prolonged follow up only "80% of all patients with epilepsy are likely to have a chronic seizure disorder. This does not rule out short-term remissions or changes in seizure patterns, it merely reemphasises that epilepsy should be regarded as a chronic condition with remissions and exacerbations." Finally, he noted that the longer the history of epilepsy the worse the prognosis and found from his review "remarkable unanimity" on this point. These conclusions have been widely accepted, but while they indubitably reflect the prognosis of chronic hospital patients, they do not hold true for most cases, as I hope to show below, and should not be applied to epilepsy as a whole.
Studies of newly diagnosed patients
In recent years, a number of prospective hospital studies of newly diagnosed patients at the onset of anticonvulsant treatment have been carried out, and their results are summarised in table 2.17-28 Regardless of treatment regime, overall prognosis has been found to be good. Rapidly attained and long lasting remission was observed in most patients, and this is a striking contrast to the much poorer results in more chronic populations. The most comprehensive studies of newly diagnosed adult patients were carried out from Kings College hospital, under the direction of Dr EH Reynolds, and here the temporal patterns of remission/relapse was looked at. '8 (table 5) . In 82% seizures recurred-a higher proportion than in hospital based studies-but the total number of attacks suffered by most patients was small (10 or less attacks in 68% of the group), and the epilepsy remained active for a short period of time only in most patients (50% of patients were in a remission of at least 2 years within 5 years of the onset of seizures). Once in remission this was usually permanent and relapse was unusual. Thus, only 10% of the patients achieved a two year remission period and then subsequently relapsed (the intermittent pattern). In 22% of the patients, the seizures did not remit (the continuous pattern), and it is these patients, and the few with the intermittent (relapsing/remitting) course who presumably make up the bulk of the chronic hospital population (whose prognosis was discussed above). Remission rates at yearly intervals are shown in fig 5, where it can be seen that nearly half the patients were in or entering terminal remission within 2 years of the onset of seizures. The percentage continued to rise slowly and by 15 years 70% were in remission.
Discussion
It is the thesis of this paper that conflicting views about prognosis for seizure control are due partly (possible largely) to the failure to appreciate the The two community based studies,3546 again of patients followed from the time of diagnosis found a good overall prognosis with eventually over 70% of all patients entering long term remission. Again in contrast to the findings from cross-sectional studies, the proportion of patients in remission continued to rise as follow up lengthened and the rate of rise was greatest in the early years after diagnosis. As shown in the Tonbridge survey,35 once remission was achieved it was usually permanent. In this survey, patterns of epilepsy were studied in more detail. The commonest was the burst pattern in which seizures were active over a period of time (without remission) and then permanent remission ensued, and the period of activity was usually relatively short (less than 5 years in three quarters). The intermittent pattern (the relapsing/remitting course-which is the traditional concept of epilepsy) was observed in a minority of patients only. Most patients with active epilepsy fell into the continuous category, in which seizures had continued without remission from their
The temporal aspects ofprognosis in epilepsy onset. Indeed, amongst those with chronic epilepsy the continuous pattern was several times commoner than was the intermittent pattern. An important deduction, which can be drawn from these studies, '8 19354647 is that the course of the seizure disorder in the early years after diagnosis can provide, with a fair degree of statistical accuracy, a useful guide to long term outcome, and those with a good and bad long term prognosis can be differentiated early on the basis of previous seizure pattern.
The importance of these points can be illustrated in specific studies in other areas. The variation, for instance, in the findings of studies of seizure recurrence after a single attack29-35 may be partly (possible largely) due to the fact that they only included patients who had not recurred by the time of referral. Similarly, the studies of withdrawal of medication-hospital based and biased towards patients with chronic epilepsy-largely exclude those cases (possibly the majority) who rapidly enter long term remission and take drugs for a relatively short period.
A synoptical view of prognosis, based on seizure relapse and remission, is represented schematically in fig 6, in which the evolution of epilepsy in a population is divided into three time periods. The first is Stage 1 1163 after a first attack; up to 5% of a general population will experience a single non-febrile seizure, and following this a second attack will occur in over one half, usually within months of the first. Most patients will then receive a diagnosis of epilepsy and initiate treatment. In the second stage, over the next few years, most patients (perhaps 70%), suffer only a small number of further attacks, usually over a relatively short period of time, and then enter a remission which is usually permanent. A large number of patients at this stage will withdraw medicationoften without hospital supervision-and most will remain free of attacks. In a smaller number of patients (about 30%) the epilepsy evolves and rapid remission does not occur. Such patients form a group of potentially chronic cases whose outlook is considerably less good. The third stage has now been reached, in which the epilepsy has either remitted or become established (chronic epilepsy). In those with continuing seizures, manipulation of treatment may result in perhaps 30% of so eventually entering long remission, but the longer the epilepsy remains active the less likely this is. Thus, within a relatively short time after the onset of seizures, the population of patients with chronic epilepsy is probably already identifiable. When Finally, the effect of treatment must be added to the equation. There is little doubt that anticonvulsant therapy can suppress seizures in the short term, and this is common experience. A more intriguing question is that of the relation of effective early treatment to the long term outlook. Prior to the introduction of bromides, Gowers and others before him were of the opinion that untreated epilepsy seldom remitted, arid that the chances of "cure" were slim. By contrast, with modern treatment, most patients go into rapid remission, which is as we have seen often permanent. This raises the possibility, first suggested by Gowers' and 
